BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9872414)

  • 1. BCL-2 promotes migration and invasiveness of human glioma cells.
    Wick W; Wagner S; Kerkau S; Dichgans J; Tonn JC; Weller M
    FEBS Lett; 1998 Dec; 440(3):419-24. PubMed ID: 9872414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus-mediated p16/CDKN2 gene transfer suppresses glioma invasion in vitro.
    Chintala SK; Fueyo J; Gomez-Manzano C; Venkaiah B; Bjerkvig R; Yung WK; Sawaya R; Kyritsis AP; Rao JS
    Oncogene; 1997 Oct; 15(17):2049-57. PubMed ID: 9366522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta.
    Wick W; Platten M; Weller M
    J Neurooncol; 2001 Jun; 53(2):177-85. PubMed ID: 11716069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma.
    Wild-Bode C; Weller M; Rimner A; Dichgans J; Wick W
    Cancer Res; 2001 Mar; 61(6):2744-50. PubMed ID: 11289157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells.
    Abe T; Mori T; Kohno K; Seiki M; Hayakawa T; Welgus HG; Hori S; Kuwano M
    Clin Exp Metastasis; 1994 Jul; 12(4):296-304. PubMed ID: 8039304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of synthetic matrix-metalloproteinase inhibitors on invasive capacity and proliferation of human malignant gliomas in vitro.
    Tonn JC; Kerkau S; Hanke A; Bouterfa H; Mueller JG; Wagner S; Vince GH; Roosen K
    Int J Cancer; 1999 Mar; 80(5):764-72. PubMed ID: 10048980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTEN gene transfer suppresses the invasive potential of human malignant gliomas by regulating cell invasion-related molecules.
    Furukawa K; Kumon Y; Harada H; Kohno S; Nagato S; Teraoka M; Fujiwara S; Nakagawa K; Hamada K; Ohnishi T
    Int J Oncol; 2006 Jul; 29(1):73-81. PubMed ID: 16773187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
    Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
    J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.
    Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y
    J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas.
    Fujiwara S; Nakagawa K; Harada H; Nagato S; Furukawa K; Teraoka M; Seno T; Oka K; Iwata S; Ohnishi T
    Int J Oncol; 2007 Apr; 30(4):793-802. PubMed ID: 17332917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular determinants of glioma cell migration and invasion.
    Wild-Bode C; Weller M; Wick W
    J Neurosurg; 2001 Jun; 94(6):978-84. PubMed ID: 11409528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
    Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS
    Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter.
    Beliƫn AT; Paganetti PA; Schwab ME
    J Cell Biol; 1999 Jan; 144(2):373-84. PubMed ID: 9922462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases in human gliomas: activation of matrix metalloproteinase-2 (MMP-2) may be correlated with membrane-type-1 matrix metalloproteinase (MT1-MMP) expression.
    Hur JH; Park MJ; Park IC; Yi DH; Rhee CH; Hong SI; Lee SH
    J Korean Med Sci; 2000 Jun; 15(3):309-14. PubMed ID: 10895974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased invasion of neuroglioma cells transfected with urokinase plasminogen activator receptor cDNA.
    Mohanam S; Chintala SK; Mohan PM; Sawaya R; Lagos GK; Gokaslan ZL; Kouraklis GP; Rao JS
    Int J Oncol; 1998 Dec; 13(6):1285-90. PubMed ID: 9824646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of angiopoietin-2, matrix metalloprotease-2, membrane type 1 metalloprotease, and laminin 5 gamma 2 correlates with the invasiveness of human glioma.
    Guo P; Imanishi Y; Cackowski FC; Jarzynka MJ; Tao HQ; Nishikawa R; Hirose T; Hu B; Cheng SY
    Am J Pathol; 2005 Mar; 166(3):877-90. PubMed ID: 15743799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloproteinase-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth.
    Lakka SS; Gondi CS; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Rao JS
    Cancer Res; 2003 May; 63(10):2454-61. PubMed ID: 12750266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line.
    Lu KV; Jong KA; Rajasekaran AK; Cloughesy TF; Mischel PS
    Lab Invest; 2004 Jan; 84(1):8-20. PubMed ID: 14631378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor cell invasion through matrigel is regulated by activated matrix metalloproteinase-2.
    Deryugina EI; Luo GX; Reisfeld RA; Bourdon MA; Strongin A
    Anticancer Res; 1997; 17(5A):3201-10. PubMed ID: 9413149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short chain fatty acids inhibit human (SW1116) colon cancer cell invasion by reducing urokinase plasminogen activator activity and stimulating TIMP-1 and TIMP-2 activities, rather than via MMP modulation.
    Emenaker NJ; Basson MD
    J Surg Res; 1998 Apr; 76(1):41-6. PubMed ID: 9695737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.